HIV and hepatitis B medications – Updated boxed warnings
April 14, 2017 – The FDA approved changes to the drug labels of several human immunodeficiency virus type 1 (HIV-1) and hepatitis B medications, to remove information related to lactic acidosis/severe hepatomegaly with steatosis from the boxed warnings.
Top